Glossary
A |
|
ADS | Analytical Decision Support |
AIG | Anthrax Immune Globulin |
AMCG | Office of Acquisition Management, Contracts, & Grants |
AMIC | Animal Model Interagency Committee |
Arenavirus | The Arenaviridae are a family of viruses whose members are generally associated with rodent-transmitted diseases in humans. Each virus usually is associated with a particular rodent host species in which it is maintained. |
Animal Efficacy Rule | The FDA Animal Efficacy Rule (also known as Animal Rule) applies to development/testing of drugs / biologicals to reduce or prevent serious/life-threatening conditions caused by exposure to lethal /permanently disabling toxic agent (chemical, biological, radiological, or nuclear substances), where human efficacy trials are not feasible or ethical |
ARS | Acute Radiation Syndrome; also known as radiation poisoning, radiation sickness or radiation toxicity, is a collection of health effects which present within 24 hours of exposure to high amounts of ionizing radiation. |
ASPR | Assistant Secretary for Preparedness and Response |
B |
|
BAA | Broad Agency Announcements |
BARDA | Biomedical Advanced Research and Development Authority |
BPN | Business Partner Network |
BSA | Broad Spectrum Antimicrobials |
C |
|
CAP | Concept Acceleration Program |
CBMS | Chemical Biological Medical Systems |
CBRN | Chemical, Biological, Radiological and Nuclear Threats |
CDC | Center for Desease Control |
CDER | Center for Drug Evaluation and Research |
CFR | Code of Federal Regulations |
CIADM | Centers for Innovation in Advanced Development and Manufacturing |
CLIA | Clinical Laboratory Improvement Amendment |
CSN | Clinical Studies Network |
D |
|
DARPA | Defense Advanced Research Projects Agency |
DCEG | Division of Cancer Epidemiology and Genetics |
DCS | Clinical Studies group |
DHS | Department of Homeland Security |
DoD | Department of Defense |
DSMB | Data Safety Monitoring Board |
DTRA | Defense Threat Reduction Agency |
E |
|
EID | Emerging Infectious Diseases |
EMS | Emergency Medical Services |
EUA | Emergency Use Authorization |
F |
|
FAR | Federal Acquisition Regulations |
FD&C | Federal Food, Drug and Cosmetic Act |
FDA | Food and Drug Administration |
FedBizOpps | Federal Business Opportunities |
FFMN | Fill Finish Manufacturing Network |
G |
|
GI | Gastrointestinal |
GPE | Government Point-of-Entry |
Back to top
H |
|
HGS | Human Genome Sciences |
HHS | U.S. Department of Health and Human Services |
HHSAR | Department of Health and Human Services Acquisition Regulation |
I |
|
IEDB | Immune Epitope Database |
IND | Investigational New Drug |
J |
|
JOFOC | Justification for Other than Full and Open Competition |
M |
|
MCM | Medical Countermeasures |
MCMi | Medical Countermeasures initiative |
MMWR | Morbidity and Mortality Weekly Report |
N |
|
NARA | National Archives and Records Administration |
NBLs | National Biocontainment Laboratories |
NCI | National Cancer Institute |
NHLBI | National Heart, Lung and Blood Institute |
NIAID | National Institute of Allergy and Infectious Diseases |
NIH | National Institutes of Health |
NINDS | National Institute of Neurological Disorders and Stroke |
NSABB | National Science Advisory Board for BioSecurity |
Back to top
O |
|
OEM | Office of Emergency Management |
OMB | Office of Management and Budget |
OPP | Office of Policy and Planning |
P |
|
PAHPA | The Pandemic and All Hazards Preparedness Act |
PBS | Project BioShield |
PDTs | Product Development Tools |
PEP | Post-Event Prophylactic |
PHCM | Public Health Consequence Modeling |
PHEMCE | Public Health Emergency Medical Countermeasures Enterprise |
PHS | Public Health Service |
R |
|
RBLs | Regional Biocontainment Laboratories |
RCE | Regional Centers of Excellence |
REB | Radiation Epidemiology Branch |
RFP | Request for Proposal |
RQA | Division of Regulatory and Quality Affairs |
RSV | Respiratory Syncytial Virus |
RTOR | Request for Task Order Response |
S |
|
SAE | Serious Adverse Event |
SIP | Strategy and Implementation Plan |
SNS | Strategic National Stockpile |
SST | Strategic Science and Technology |
T |
|
TICs | Toxic Industrial Chemicals |
TIMs | Toxic Industrial Materials |
TMTI | Transformational Medical Technologies Initiative |
TRA | Terrorism Risk Assessment |
TRLs | Technology Readiness Levels |